热门资讯> 正文

CompASS Pathways ADS GAAP每股收益为-1.88美元

2026-08-05 18:38

COMPASS Pathways(CMPS) 0

COMPASS Pathways ADS press release (CMPS): 1H GAAP EPS of -$1.88.
Cash and cash equivalents were $433.3 million as of June 30, 2026, compared with $149.6 million as of December 31, 2025.
Debt was $50.7 million as of June 30, 2026, compared with $31.6 million as of December 31, 2025.
Financial Guidance
The current cash position is expected to be sufficient to fund operating expenses and capital expenditure requirements into 2028.

More on COMPASS Pathways ADS

Compass Pathways: The Psilocybin Biotech Leader With Strong Momentum
Compass Pathways: 'Strong Buy' COMP360 Trial Wins And Q4 NDA Full Submission
Compass Pathways Phase 3 COMP006 Data Review
Psilocybin shown to ease PTSD in veterans in small study
Psychedelic drugmakers could get boost from HHS, VA memorandum

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。